Compare
Beyond Air, Inc. vs INVO Fertility, Inc. vs InspireMD, Inc. vs Neuroone Medical Technologies Corp
| Latest fiscal year | Beyond Air, Inc. XAIR | INVO Fertility, Inc. IVF | InspireMD, Inc. NSPR | Neuroone Medical Technologies Corp NMTC |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $7.68M | $6.84M | $8.98M | $9.10M |
| Revenue growth (YoY) | +107.3% | +4.7% | +28.1% | +163.5% |
| Gross margin | 3.3% | n/a | 29.5% | 56.5% |
| Operating margin | -378.2% | -105.8% | -552.6% | -46.5% |
| Net margin | -433.0% | -340.9% | -543.3% | -39.6% |
| Net income | -$33.25M | -$23.32M | -$48.79M | -$3.61M |
| EPS (Diluted) | -$4.01 | -$214.64 | -$0.76 | -$0.09 |
| Operating cash flow | -$18.14M | -$7.01M | -$35.10M | -$2.84M |
| Free cash flow | -$19.17M | -$7.06M | -$36.77M | -$2.92M |
| Cash & equivalents | $6.74M | n/a | $8.94M | $6.57M |
| Total assets | $35.38M | $20.22M | $69.40M | $10.79M |
| Total liabilities | $29.18M | $13.00M | $14.20M | $3.71M |
| Shareholders' equity | $6.13M | $7.22M | $55.20M | $7.07M |
| Return on year-end equity | -542.8% | -322.8% | -88.4% | -51.0% |
| Shares outstanding | 11.79M | 477.4K | 43.53M | 50.01M |
Revenue, most recent five fiscal years
| Fiscal year | Beyond Air, Inc. | INVO Fertility, Inc. | InspireMD, Inc. | Neuroone Medical Technologies Corp |
|---|---|---|---|---|
| Latest | $7.68M Ended 2026-03-31 | $6.84M Ended 2025-12-31 | $8.98M Ended 2025-12-31 | $9.10M Ended 2025-09-30 |
| 1 year earlier | $3.71M Ended 2025-03-31 | $6.53M Ended 2024-12-31 | $7.01M Ended 2024-12-31 | $3.45M Ended 2024-09-30 |
| 2 years earlier | $1.16M Ended 2024-03-31 | $3.02M Ended 2023-12-31 | $6.21M Ended 2023-12-31 | $1.95M Ended 2023-09-30 |
| 3 years earlier | n/a | n/a | $5.17M Ended 2022-12-31 | $171.2K Ended 2022-09-30 |
| 4 years earlier | n/a | n/a | $4.50M Ended 2021-12-31 | $178.1K Ended 2021-09-30 |